BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 110621
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.110621
Table 4 Serum tumor marker levels in the two groups, mean ± SD
GroupCA125 (kU/L)
CA153 (U/mL)
CA199 (U/mL)
Before treatment
After treatment
Before treatment
After treatment
Before treatment
After treatment
Bevacizumab + radiotherapy group (n = 35)31.44 ± 52.336.29 ± 1.23a18.95 ± 29.5530.21 ± 3.66a50.12 ± 65.886.45 ± 1.12a
Bevacizumab only group (n = 35)34.73 ± 53.267.36 ± 1.42a17.53 ± 11.1435.26 ± 3.85a51.33 ± 72.729.10 ± 1.32a
t0.2604.4740.2657.1940.07312.438
P value0.795< 0.0010.792< 0.0010.942< 0.001


Write to the Help Desk